These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27889632)

  • 1. Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
    Joshi SD; Dixit SR; Kulkarni VH; Lherbet C; Nadagouda MN; Aminabhavi TM
    Eur J Med Chem; 2017 Jan; 126():286-297. PubMed ID: 27889632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approach.
    More UA; Joshi SD; Aminabhavi TM; Kulkarni VH; Badiger AM; Lherbet C
    Eur J Med Chem; 2015 Apr; 94():317-39. PubMed ID: 25771110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
    Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore mapping, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; Dixit SR; Basha J; Kulkarni VH; Aminabhavi TM; Nadagouda MN; Lherbet C
    Bioorg Chem; 2018 Dec; 81():440-453. PubMed ID: 30223149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolyl Pyrazoline Carbaldehydes as Enoyl-ACP Reductase Inhibitors: Design, Synthesis and Antitubercular Activity.
    Dixit SR; Joshi SD; Kulkarni VH; Jalalpure SS; Kumbar VM; Mudaraddi TY; Nadagouda MN; Aminabhavi TM
    Open Med Chem J; 2017; 11():92-108. PubMed ID: 29151986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.
    Mahnashi MH; Avunoori S; Gopi S; Shaikh IA; Saif A; Bantun F; Faidah HS; Alhadi AA; Alshehri JH; Alharbi AA; S R PK; Joshi SD
    PLoS One; 2024; 19(5):e0303173. PubMed ID: 38739587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.
    More UA; Joshi SD; Aminabhavi TM; Gadad AK; Nadagouda MN; Kulkarni VH
    Eur J Med Chem; 2014 Jan; 71():199-218. PubMed ID: 24292339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, evaluation and in silico molecular modeling of pyrroyl-1,3,4-thiadiazole inhibitors of InhA.
    Joshi SD; More UA; Koli D; Kulkarni MS; Nadagouda MN; Aminabhavi TM
    Bioorg Chem; 2015 Apr; 59():151-67. PubMed ID: 25800133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
    Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational approach to identify inhibitors of Mycobacterium tuberculosis enoyl acyl carrier protein reductase.
    Chhabria MT; Parmar KB; Brahmkshatriya PS
    Curr Pharm Des; 2013; 19(21):3878-83. PubMed ID: 23477735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
    Kim YG; Seo JH; Kwak JH; Shin KJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4481-6. PubMed ID: 26343826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
    Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis.
    Lone MY; Athar M; Gupta VK; Jha PC
    J Mol Graph Model; 2017 Sep; 76():172-180. PubMed ID: 28734205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.
    Jordan CA; Sandoval BA; Serobyan MV; Gilling DH; Groziak MP; Xu HH; Vey JL
    Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1521-30. PubMed ID: 26625295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
    Zheng CJ; Sohn MJ; Chi SW; Kim WG
    J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
    Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
    Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
    Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.